<?xml version="1.0" encoding="UTF-8"?>
<ref id="R34">
 <label>34</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Laouénan</surname>
    <given-names>C</given-names>
   </name>, 
   <name name-style="western">
    <surname>Guedj</surname>
    <given-names>J</given-names>
   </name>, 
   <name name-style="western">
    <surname>Peytavin</surname>
    <given-names>G</given-names>
   </name>, 
   <etal>et al</etal>
  </person-group>
  <article-title>A model-based illustrative exploratory approach to optimize the dosing of Peg-IFN/RBV in cirrhotic hepatitis C patients treated with triple therapy</article-title>. 
  <source>CPT Pharmacometrics Syst Pharmacol</source>
  <year>2015</year>;
  <volume>4</volume>:
  <elocation-id>e00008</elocation-id>:
  <fpage>37</fpage>–
  <lpage>40</lpage>. 
  <pub-id pub-id-type="doi">10.1002/psp4.8</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/26225222?>
  <pub-id pub-id-type="pmid">26225222</pub-id>
 </mixed-citation>
</ref>
